Talking O&G - a RANZCOG Podcast delivers expert insights and up-to-date clinical information in obstetrics and gynaecology. Created for RANZCOG members, trainees, and healthcare professionals, each episode features evidence-based discussions on essential topics—from miscarriage and vasa praevia to contraception, abortion, and more. Available in both audio and video formats, with new episodes released fortnightly via ranzcog.edu.au/podcasts, Spotify, Apple Podcasts, YouTube, and all major platforms.
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Vijaya Karanam speaks to obstetrician Dr Penny Sheehan, consumer Yvonne Maringa, and midwife Deborah Pidd about the vital role informed consent plays in everyday clinical practice. They outline the fundamentals of the recently released signposting guideline Consent and provision of information to patients regarding proposed treatments (C-Gen 2). Dr Sheehan and Ms Pidd discuss the responsibilities of clinicians to ensure patients are informed, respected, and feel empowered to ask questions and engage in shared decision-making. They emphasise that consent is relational, not transactional, and establishing a relationship of trust is essential. Ms Maringa shares what good informed consent looks like and means to the patient, and how clinicians can help them to feel informed and safe even in high-pressure, time-sensitive situations. They all highlight the importance of patient-centred, culturally responsive, and individualised care as core aspects of embedding informed consent into practice. 🔗 Resources mentioned in this episode: Consent and provision of information to patients regarding proposed treatment (C-Gen 2) Signposting Statement to National Guidance Safer Care Victoria: Respectful Maternity and Newborn Care Framework The Mothers on Respect (MOR) index: measuring quality, safety, and human rights in childbirth The Mother’s Autonomy in Decision Making (MADM) scale: Patient-led development and psychometric testing of a new instrument to evaluate experience of maternity care 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Vijaya Karanam speaks to obstetrician Dr Penny Sheehan, consumer Yvonne Maringa, and midwife Deborah Pidd about the vital role informed consent plays in everyday clinical practice. They outline the fundamentals of the recently released signposting guideline Consent and provision of information to patients regarding proposed treatments (C-Gen 2). Dr Sheehan and Ms Pidd discuss the responsibilities of clinicians to ensure patients are informed, respected, and feel empowered to ask questions and engage in shared decision-making. They emphasise that consent is relational, not transactional, and establishing a relationship of trust is essential. Ms Maringa shares what good informed consent looks like and means to the patient, and how clinicians can help them to feel informed and safe even in high-pressure, time-sensitive situations. They all highlight the importance of patient-centred, culturally responsive, and individualised care as core aspects of embedding informed consent into practice. 🔗 Resources mentioned in this episode: Consent and provision of information to patients regarding proposed treatment (C-Gen 2) Signposting Statement to National Guidance Safer Care Victoria: Respectful Maternity and Newborn Care Framework The Mothers on Respect (MOR) index: measuring quality, safety, and human rights in childbirth The Mother’s Autonomy in Decision Making (MADM) scale: Patient-led development and psychometric testing of a new instrument to evaluate experience of maternity care 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Roshan Zeirideen Zaid speaks to Dr Keeth Mayakaduwage and Dr Penny Sheehan about the impacts and implementation of the Safer Baby Bundle, Australia’s national initiative to reduce the number of stillborn babies by 20%. Dr Mayakaduwage and Dr Sheehan outline the context of stillbirth in Australia and the targets of the Safer Baby Bundle. They examine the key components of the bundle, including its cultural adaptations for First Nations and migrant and refugee communities. Dr Mayakaduwage presents the central findings of an ANZJOG research series which examined the early impacts of the bundle in Victoria, on which he was lead author. Dr Sheehan shares her experience implementing the bundle in clinical practice and provides recommendations for clinicians wishing to strengthen its impact in their own jurisdictions. 🔗 Resources mentioned in this episode: The Safer Baby Bundle Stronger Bubba Born Growing a Healthy Baby Stillbirth Centre of Research Excellence eLearning Resources ANZJOG: Reducing Perinatal Mortality in Victoria, Australia: Early Insights from the Safer Baby Bundle Implementation ANZJOG: Impacts on Causes of Perinatal Death After Safer Baby Bundle Implementation in Victoria, Australia ANZJOG: Reach and Impact of the Safer Baby Bundle Among Groups Disproportionately Affected by Stillbirth in Victoria, Australia 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Roshan Zeirideen Zaid speaks to Dr Keeth Mayakaduwage and Dr Penny Sheehan about the impacts and implementation of the Safer Baby Bundle, Australia’s national initiative to reduce the number of stillborn babies by 20%. Dr Mayakaduwage and Dr Sheehan outline the context of stillbirth in Australia and the targets of the Safer Baby Bundle. They examine the key components of the bundle, including its cultural adaptations for First Nations and migrant and refugee communities. Dr Mayakaduwage presents the central findings of an ANZJOG research series which examined the early impacts of the bundle in Victoria, on which he was lead author. Dr Sheehan shares her experience implementing the bundle in clinical practice and provides recommendations for clinicians wishing to strengthen its impact in their own jurisdictions. 🔗 Resources mentioned in this episode: The Safer Baby Bundle Stronger Bubba Born Growing a Healthy Baby Stillbirth Centre of Research Excellence eLearning Resources ANZJOG: Reducing Perinatal Mortality in Victoria, Australia: Early Insights from the Safer Baby Bundle Implementation ANZJOG: Impacts on Causes of Perinatal Death After Safer Baby Bundle Implementation in Victoria, Australia ANZJOG: Reach and Impact of the Safer Baby Bundle Among Groups Disproportionately Affected by Stillbirth in Victoria, Australia 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Anna Clare speaks with Conj A/Prof Tania Day about gynaecologists' role in prevention of vulvar squamous cell carcinoma by identifying and treating vulvar intraepithelial neoplasia (VIN) and distinguishing these from benign squamous intraepithelial lesions (SIL). They unpack the recently published 2026 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology guide, on which Conj A/Prof Day was lead author. The ISSVD terminology was last updated in 2015, and there have since been major advancements in the clinical understanding of VIN histopathology and immunohistochemistry. Dr Clare and Conj A/Prof Day examine these developments, outlining the new preferred terminology, as well as diagnosis, treatment, and follow up. They highlight the importance of consistent language to aid collective efforts in vulval cancer elimination. 🔗 Resources mentioned in this episode: 2026 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology for vulvar intraepithelial neoplasia and squamous intraepithelial lesions 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Anna Clare speaks with Conj A/Prof Tania Day about gynaecologists' role in prevention of vulvar squamous cell carcinoma by identifying and treating vulvar intraepithelial neoplasia (VIN) and distinguishing these from benign squamous intraepithelial lesions (SIL). They unpack the recently published 2026 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology guide, on which Conj A/Prof Day was lead author. The ISSVD terminology was last updated in 2015, and there have since been major advancements in the clinical understanding of VIN histopathology and immunohistochemistry. Dr Clare and Conj A/Prof Day examine these developments, outlining the new preferred terminology, as well as diagnosis, treatment, and follow up. They highlight the importance of consistent language to aid collective efforts in vulval cancer elimination. 🔗 Resources mentioned in this episode: 2026 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology for vulvar intraepithelial neoplasia and squamous intraepithelial lesions 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Scott White speaks to Dr Penny Sheehan about RANZCOG’s updated binational clinical guideline for Intrapartum Fetal Surveillance (C-Obs 1). They discuss recommendations for antenatal and intrapartum risk factors and models of care, cases involving fetal sepsis, the use of tocolysis in cases of prolonged deceleration, and more. They look at the evidence around alternative methods for fetal assessment, such as fetal scalp stimulation and fetal blood sampling, and new and emerging technologies. The broader process of the guideline development is also explored, including the implementation of the GRADE system to assess evidence, and the guiding principles of care addressed in the guideline. 🔗 Resources mentioned in this episode: Intrapartum Fetal Surveillance (C-Obs 1) Clinical Guideline Respectful Maternity and Newborn Care Framework Fetal Surveillance Education Program (FSEP) 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Scott White speaks to Dr Penny Sheehan about RANZCOG’s updated binational clinical guideline for Intrapartum Fetal Surveillance (C-Obs 1). They discuss recommendations for antenatal and intrapartum risk factors and models of care, cases involving fetal sepsis, the use of tocolysis in cases of prolonged deceleration, and more. They look at the evidence around alternative methods for fetal assessment, such as fetal scalp stimulation and fetal blood sampling, and new and emerging technologies. The broader process of the guideline development is also explored, including the implementation of the GRADE system to assess evidence, and the guiding principles of care addressed in the guideline. 🔗 Resources mentioned in this episode: Intrapartum Fetal Surveillance (C-Obs 1) Clinical Guideline Respectful Maternity and Newborn Care Framework Fetal Surveillance Education Program (FSEP) 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Heather Waterfall speaks with Dr Marilla Druitt about multidisciplinary management and treatment options for persistent pelvic pain. Pelvic pain affects one in five women in Australia and up to one in four women in Aotearoa New Zealand at some point in their life. Contributors are broad, and may include conditions such endometriosis or adenomyosis, antenatal or postpartum pain, or irritable bowel syndrome. Dr Waterfall and Dr Druitt address a range of treatment and prevention approaches, including hormonal treatment, physiotherapy, pain psychology, nutrition, and more. They highlight the biopsychosocial components of pelvic pain and its comorbidities and recommend a holistic approach to care. They also emphasise the importance of focusing on prevention, to reduce the potential development of severe pain. This episode was recorded in February 2026. Please refer to the PBS website for up-to-date information on medication availability and subsidies. 🔗 Resources mentioned in this episode: Australian Living Evidence Guideline: Endometriosis Pelvic Pain Foundation of Australia: Stretches, Strategies and Acupressure Guides Queensland Government Flowchart: Acute presentation of persistent pelvic pain Greene Climacteric Scale 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Heather Waterfall speaks with Dr Marilla Druitt about multidisciplinary management and treatment options for persistent pelvic pain. Pelvic pain affects one in five women in Australia and up to one in four women in Aotearoa New Zealand at some point in their life. Contributors are broad, and may include conditions such endometriosis or adenomyosis, antenatal or postpartum pain, or irritable bowel syndrome. Dr Waterfall and Dr Druitt address a range of treatment and prevention approaches, including hormonal treatment, physiotherapy, pain psychology, nutrition, and more. They highlight the biopsychosocial components of pelvic pain and its comorbidities and recommend a holistic approach to care. They also emphasise the importance of focusing on prevention, to reduce the potential development of severe pain. This episode was recorded in February 2026. Please refer to the PBS website for up-to-date information on medication availability and subsidies. 🔗 Resources mentioned in this episode: Australian Living Evidence Guideline: Endometriosis Pelvic Pain Foundation of Australia: Stretches, Strategies and Acupressure Guides Queensland Government Flowchart: Acute presentation of persistent pelvic pain Greene Climacteric Scale 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Nisha Khot speaks with Professor Lisa Hui and Associate Professor Natasha Holmes about the clinical utility of TORCH – Toxoplasma gondii, rubella, cytomegalovirus (CMV), and herpes simplex virus (HSV) – serology in isolated fetal growth restriction (FGR). Professor Hui and A/Prof Holmes co-authored a study on this topic, considering whether TORCH serology should continue to be ordered for isolated FGR. They examine the importance of differentiating early- and late-onset FGR, how their findings reflect international screening recommendations, and whether TORCH screening can be a reassuring measure for patients. They highlight the waste of resources and potential increase of maternal anxiety associated with ordering TORCH serology in situations where it is clinically unnecessary. 🔗 Resources mentioned in this episode: Clinical utility of maternal TORCH screening in fetal growth restriction: A retrospective two-centre study 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Nisha Khot speaks with Professor Lisa Hui and Associate Professor Natasha Holmes about the clinical utility of TORCH – Toxoplasma gondii, rubella, cytomegalovirus (CMV), and herpes simplex virus (HSV) – serology in isolated fetal growth restriction (FGR). Professor Hui and A/Prof Holmes co-authored a study on this topic, considering whether TORCH serology should continue to be ordered for isolated FGR. They examine the importance of differentiating early- and late-onset FGR, how their findings reflect international screening recommendations, and whether TORCH screening can be a reassuring measure for patients. They highlight the waste of resources and potential increase of maternal anxiety associated with ordering TORCH serology in situations where it is clinically unnecessary. 🔗 Resources mentioned in this episode: Clinical utility of maternal TORCH screening in fetal growth restriction: A retrospective two-centre study 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Anna Clare and Conjoint Associate Professor Tania Day discuss diagnosis and treatment recommendations for vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV) – two common and impactful conditions with high recurrence rates. Dr Clare and Conj A/Prof Day examine recent and emerging research on these conditions, unpack common myths and misconceptions, and discuss their experiences diagnosing and treating them in their clinical practice. They touch on a range of long-term management strategies including male partner treatment of BV and the role of the microbiome in both conditions. 🔗 Resources mentioned in this episode: Recommendations for the Diagnosis and Treatment of Vaginitis Clinician instructions for BV partner treatment Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations Nature Reviews Disease Primer: Bacterial vaginosis 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Anna Clare and Conjoint Associate Professor Tania Day discuss diagnosis and treatment recommendations for vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV) – two common and impactful conditions with high recurrence rates. Dr Clare and Conj A/Prof Day examine recent and emerging research on these conditions, unpack common myths and misconceptions, and discuss their experiences diagnosing and treating them in their clinical practice. They touch on a range of long-term management strategies including male partner treatment of BV and the role of the microbiome in both conditions. 🔗 Resources mentioned in this episode: Recommendations for the Diagnosis and Treatment of Vaginitis Clinician instructions for BV partner treatment Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations Nature Reviews Disease Primer: Bacterial vaginosis 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Scott White speaks to Dr Natasha Frawley and Dr Magdalena Halt about RANCOG’s new clinical guideline for Robotic Assisted Surgery in Gynaecology, Urogynaecology and Gynae-oncology (C-Gyn 29). This guideline builds on and broadens the scope of the College’s 2009 Position Statement on Robotic Assisted Laparoscopy. Robotic assisted surgery is growing rapidly – as of May 2023, there were 162 robotic surgical platforms in Australia and Aotearoa New Zealand, and this number continues to rise. Dr Frawley and Dr Halt explore the current evidence surrounding robotic assisted gynaecological surgery compared to open or laparoscopic procedures, areas that require further research, and the environmental implications of this approach. They discuss their own clinical experiences with robotic platforms and highlight some of the access issues currently associated with robotic assisted surgery. 🔗 Resources mentioned in this episode: Robotic Assisted Surgery in Gynaecology, Urogynaecology and Gynae-oncology (C-Gyn 29) Clinical Guideline 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). This podcast is not sponsored by any technology companies. Our aim is to deliver balanced, evidence-based discussion. Any views expressed are those of the speaker and do not reflect brand endorsement by RANZCOG.
In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Scott White speaks to Dr Natasha Frawley and Dr Magdalena Halt about RANCOG’s new clinical guideline for Robotic Assisted Surgery in Gynaecology, Urogynaecology and Gynae-oncology (C-Gyn 29). This guideline builds on and broadens the scope of the College’s 2009 Position Statement on Robotic Assisted Laparoscopy. Robotic assisted surgery is growing rapidly – as of May 2023, there were 162 robotic surgical platforms in Australia and Aotearoa New Zealand, and this number continues to rise. Dr Frawley and Dr Halt explore the current evidence surrounding robotic assisted gynaecological surgery compared to open or laparoscopic procedures, areas that require further research, and the environmental implications of this approach. They discuss their own clinical experiences with robotic platforms and highlight some of the access issues currently associated with robotic assisted surgery. 🔗 Resources mentioned in this episode: Robotic Assisted Surgery in Gynaecology, Urogynaecology and Gynae-oncology (C-Gyn 29) Clinical Guideline 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). This podcast is not sponsored by any technology companies. Our aim is to deliver balanced, evidence-based discussion. Any views expressed are those of the speaker and do not reflect brand endorsement by RANZCOG.
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Heather Waterfall delves into breastfeeding care with Dr Briony Andrew and Dr Jacqui Wagner, GP Obstetricians and International Board-Certified Lactation Consultants. Breastfeeding has been proven to have significant health benefits for both mother and baby. However, many mothers require help and support to overcome common challenges such as low supply, or pain during feeding. Research has found that only 17-22% of babies in Aotearoa New Zealand and 29-37% of babies in Australia are exclusively breastfed at six months. It is vital that women’s healthcare professionals are equipped with evidence-based recommendations and resources to support new mothers on their breastfeeding journeys. Dr Andrew and Dr Wagner unpack antenatal education and expression of colostrum, common complications such as mastitis and blocked ducts, low supply, taking medications while breastfeeding, and much more. They emphasise that no two breastfeeding experiences are the same, and so individualised care is essential to support the best outcomes for mother and baby. 🔗 Resources mentioned in this episode: Drugs and Lactation Database (LactMed®) E-Lactancia MotherToBaby Fact Sheets Academy of Breastfeeding Medicine Protocols 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Heather Waterfall delves into breastfeeding care with Dr Briony Andrew and Dr Jacqui Wagner, GP Obstetricians and International Board-Certified Lactation Consultants. Breastfeeding has been proven to have significant health benefits for both mother and baby. However, many mothers require help and support to overcome common challenges such as low supply, or pain during feeding. Research has found that only 17-22% of babies in Aotearoa New Zealand and 29-37% of babies in Australia are exclusively breastfed at six months. It is vital that women’s healthcare professionals are equipped with evidence-based recommendations and resources to support new mothers on their breastfeeding journeys. Dr Andrew and Dr Wagner unpack antenatal education and expression of colostrum, common complications such as mastitis and blocked ducts, low supply, taking medications while breastfeeding, and much more. They emphasise that no two breastfeeding experiences are the same, and so individualised care is essential to support the best outcomes for mother and baby. 🔗 Resources mentioned in this episode: Drugs and Lactation Database (LactMed®) E-Lactancia MotherToBaby Fact Sheets Academy of Breastfeeding Medicine Protocols 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Nisha Khot speaks to Associate Professor Stefan Kane and Professor Joshua Vogel about the 2025 consolidated guidelines for the prevention, diagnosis, and treatment of postpartum haemorrhage (PPH). These guidelines were released as a collaboration between the World Health Organization (WHO), the International Federation of Gynecology and Obstetrics (FIGO), and the International Confederation of Midwives (ICM). A/Prof Kane and Professor Vogel discuss the guideline’s change in diagnostic threshold for PPH, recommended preventative interventions, first-response treatments, refractory PPH treatments, and more. They highlight the importance of addressing the physical, emotional, and psychological impacts of PPH, and provide advice for clinicians adapting these international guidelines into local contexts. 🔗 Resources mentioned in this episode: Consolidated guidelines for the prevention, diagnosis and treatment of postpartum haemorrhage 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
In this episode of Talking O&G: a RANZCOG Podcast, host Dr Nisha Khot speaks to Associate Professor Stefan Kane and Professor Joshua Vogel about the 2025 consolidated guidelines for the prevention, diagnosis, and treatment of postpartum haemorrhage (PPH). These guidelines were released as a collaboration between the World Health Organization (WHO), the International Federation of Gynecology and Obstetrics (FIGO), and the International Confederation of Midwives (ICM). A/Prof Kane and Professor Vogel discuss the guideline’s change in diagnostic threshold for PPH, recommended preventative interventions, first-response treatments, refractory PPH treatments, and more. They highlight the importance of addressing the physical, emotional, and psychological impacts of PPH, and provide advice for clinicians adapting these international guidelines into local contexts. 🔗 Resources mentioned in this episode: Consolidated guidelines for the prevention, diagnosis and treatment of postpartum haemorrhage 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
